With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 45220.0 shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $1.11 whereas the lowest price it dropped to was $0.9895. The 52-week range on INCR shows that it touched its highest point at $1.79 and its lowest point at $1.02 during that stretch. It currently has a 1-year price target of $1.43. Beta for the stock currently stands at 0.93.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INCR was down-trending over the past week, with a drop of -19.27%, but this was down by -25.77% over a month. Three-month performance dropped to -39.45% while six-month performance fell -32.91%. The stock lost -37.55% in the past year, while it has lost -40.89% so far this year.
Float and Shares Shorts:
At present, 45.57 million INCR shares are outstanding with a float of 40.01 million shares on hand for trading. On 2025-12-15, short shares totaled 13558.0, which was 2.0 higher than short shares on 1763078400. In addition to Mr. Alexander Rabinovich as the firm’s CEO & Chairman, Mr. Amos Cohen serves as its Chief Financial Officer.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INCR since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0 being high and $0 being low. For INCR, this leads to a yearly average estimate of $0. The surprise factor in the prior quarter was $0.01.
